Skip to Main Content

Paper Details

Assessing the <i>In Vivo</i> Effectiveness of Cationic Lipid Nanoparticles with a Triple Adjuvant for Intranasal Vaccination against the Respiratory Pathogen <i>Bordetella pertussis</i>.
Mol Pharm
5
2022
Author NameAffiliation
Robert E W HancockUniversity of British Columbia
  • 1 - 1

Datasets

Release 1.2